Personal Care & OTC: How to Enter the United States

How to Enter the United States Personal Care & OTC Market: 7 Essential Steps

The United States remains one of the most attractive markets for beauty, wellness, and self-care brands, but entering the Personal Care & OTC category is more complex than launching in many other countries. In 2026, brands face a demanding mix of FDA oversight, retailer expectations, pricing pressure, and channel fragmentation. A moisturizer, acne treatment, sunscreen, pain relief patch, medicated shampoo, or intimate wellness product may all sit near each other on shelf, but they do not face the same compliance path.

For global brands pursuing global expansion, the US is rarely a market where “translate the packaging and find a distributor” is enough. Success depends on understanding how your product is classified, what your claims trigger, which retail channels fit your margin structure, and what listing requirements buyers and marketplaces expect before they even review your pitch. The brands that win do the operational work before they spend on sales outreach.

This guide breaks the process into seven ranked priorities. If you are building a US market entry plan for Personal Care & OTC, use this as a practical framework for launch sequencing, regulatory compliance, and retail readiness.

1. Determine Whether Your Product Is Personal Care, Cosmetic, Drug, or OTC

Your first and most important decision is not channel selection or packaging design. It is classification. In the United States, the FDA regulates products based on intended use, ingredients, and claims. A basic body lotion may fall into cosmetic or personal care territory, while a lotion that claims to treat eczema, relieve itching, or provide therapeutic skin protection could move into drug or OTC status. Sunscreen, anti-dandruff shampoo, acne treatments, antiperspirants, and many medicated oral care products are common examples where brands underestimate the regulatory implications.

This classification drives nearly everything that follows: label structure, facility obligations, ingredient review, testing expectations, retailer onboarding, and digital claim language. Many international brands make the mistake of using claims that are acceptable in their home market but create a drug claim in the US. Phrases such as “heals,” “treats,” “prevents infection,” “clinically relieves,” or “repairs damaged skin barrier” can materially change your compliance risk depending on context. The cost of getting this wrong is high: relabeling, delayed shipment release, Amazon suppression, retailer rejection, or legal exposure.

If there is uncertainty, brands should conduct a claim and label review before finalizing artwork. This is where an AI Label Compliance Analysis ($599) can help identify obvious FDA-triggering language early, before inventory is printed. It is far cheaper to adjust a claim deck than to rework a full launch after buyer presentations have already started.

Takeaway: Before investing in sales or marketing, confirm how the FDA is likely to view your product and claims in the US.

2. Build Compliance Into the Product, Label, and Claims Strategy

Once classification is clear, compliance becomes a commercial issue, not just a legal one. In the US Personal Care & OTC market, labels are selling tools, but they are also regulatory documents. Retail buyers and marketplace teams will evaluate front-panel claims, directions, warnings, ingredient declarations, and formatting. If your product enters OTC territory, the expectations around Drug Facts panels, active ingredients, and required statements become especially important. A package that looks premium but fails on technical requirements will not survive retailer onboarding.

Brands should review three claim layers separately: packaging claims, website and marketplace claims, and social/influencer claims. In 2026, enforcement risk increasingly extends beyond the physical label. A compliant carton paired with aggressive Amazon bullets or unsupported paid media claims still creates exposure. This matters in categories such as acne, SPF, anti-fungal, sleep aids, topical pain relief, and feminine wellness, where marketers often overstate efficacy or imply disease treatment. Claims also need to align with substantiation; “dermatologist tested” or “clinically proven” should not appear unless supported appropriately.

US retailers also expect consistency. If your PDP says one thing, your shipper says another, and your label omits required language, your credibility drops quickly with both buyers and compliance teams. For this reason, many brands audit all launch-facing materials together rather than treating packaging as a standalone project. US Brand Launch’s BrandVault can be useful for centralizing approved product claims, retail assets, and compliance-sensitive copy before outreach begins.

Takeaway: Treat regulatory compliance as part of your go-to-market system, covering packaging, ecommerce listings, and promotional language together.

3. Choose the Right Entry Route: Distributor, Direct Retail, or Marketplace-First

There is no single best way to enter the US Personal Care & OTC market. The right route depends on your category, price point, regulatory complexity, and internal US operating capacity. Some brands need a distributor because they lack importer infrastructure, domestic warehousing, or relationships with regional chains. Others are better suited to a direct model if they have strong margins, established operations, and enough differentiation to justify buyer attention. A third path is marketplace-first: launching on Amazon or DTC to prove demand before approaching physical retail.

For OTC-adjacent or highly regulated categories, distributor selection should go beyond sales reach. You need to know whether the partner understands your subcategory, manages compliance-sensitive products, and can support listing setup with retailers that require detailed documentation. In personal care, a distributor with salon, specialty beauty, or wellness placement may be ideal; in OTC, a partner with drug, grocery, mass, or pharmacy exposure may be more relevant. The wrong fit often produces slow sell-in, pricing erosion, and poor buyer targeting.

Marketplace-first can be attractive because it lowers the cost of testing assortment, price elasticity, and consumer messaging. It also creates useful sales data for retail pitches. However, marketplace performance is not automatic. Personal Care & OTC listings need compliant copy, conversion-oriented imagery, strong review generation systems, and often a differentiated value proposition. Brands launching this route should consider an Amazon Listing Audit before scaling paid traffic, particularly if they plan to use Amazon performance as proof for retail buyers.

Takeaway: Select an entry model that matches your operational reality and channel economics, not just your growth ambition.

4. Prioritize the US Retail Channels That Match Your Product Type

One of the biggest mistakes in US market entry is treating all retail channels as interchangeable. They are not. In Personal Care & OTC, channel fit affects velocity, margin, promotional load, and even packaging decisions. Drug chains, grocery, natural/specialty, mass merchants, club, prestige beauty, professional channels, and online marketplaces each have different customer expectations and category benchmarks. A premium personal care line with elevated packaging may perform well in specialty beauty or clean wellness retail, while a value-positioned OTC topical may need mass or drug volume to work.

Retail buyers in the US also think in category roles. They are not just asking whether your product is good; they are asking whether it fills a whitespace in their assortment, drives incrementality, and supports shelf productivity. A buyer in grocery may want proven repeat purchase and mainstream pricing. A specialty wellness buyer may accept a higher price if the brand has ingredient differentiation, social proof, and education assets. An Amazon consumer may prioritize reviews, subscriptions, and side-by-side comparison advantages. Your pitch should change accordingly.

Below is a simplified view of common channel characteristics for Personal Care & OTC brands entering the US:

Before outreach, many brands benefit from a US Market Snapshot ($349) or the deeper full US Launch Report ($599) to identify realistic channel priorities, competitor price ladders, and retailer fit. Entering the wrong channel first can create poor sales history that follows the brand into later buyer conversations.

Takeaway: Focus on the US channels where your pricing, claims profile, and brand story naturally fit buyer expectations.

5. Prepare for Listing Requirements Before Contacting Retail Buyers

US listing requirements are often more burdensome than first-time entrants expect. Buyers may like the product and still delay approval because the back-end setup is incomplete. Depending on channel, you may need UPCs, case pack details, dimensions, product hierarchy data, ingredient documents, liability insurance, W-9 or equivalent tax setup, warehouse information, EDI capability, retailer forms, image standards, and category-specific compliance confirmations. For OTC products, the documentation burden can be even heavier.

Retailers also assess practical shelf readiness: Do you have a clear MSRP and wholesale architecture? Can your packaging survive distribution? Are your case packs efficient? Are your labels readable at shelf? Will your assortment create consumer confusion? In beauty and wellness, strong branding can open the meeting, but operational detail usually determines whether the SKU gets listed. In mass and drug especially, the buyer and replenishment teams need confidence that your item can flow through their systems without creating exceptions.

A strong buyer pack should include more than a presentation deck. It should include a concise assortment strategy, hero SKU logic, promotional assumptions, competitive pricing, retailer-specific rationale, and core onboarding documents. Brands that arrive with this level of preparation are taken more seriously, particularly if they are new to the US. Internal teams should stress-test these materials before outreach, using realistic buyer questions rather than generic pitch language.

Takeaway: Retail sell-in depends as much on operational readiness and data quality as it does on brand appeal.

6. Localize Pricing, Packaging, and Merchandising for US Consumer Expectations

Winning in the United States is rarely a matter of copying what worked elsewhere. Pack sizes, scent preferences, format conventions, benefit hierarchy, and price thresholds can vary sharply from market to market. A global brand may be premium in one country and overpriced in the US set. An OTC item sold as a general wellness solution abroad may need clearer symptom-led communication for US shoppers. Personal care products may also need stronger front-of-pack cues around key ingredients, texture, fragrance-free status, dermatologist relevance, or problem-solution messaging.

Localization also matters for merchandising. US retailers often want a clear “good-better-best” story, obvious consumer need states, and line architecture that is easy to shop. Overly broad ranges can hurt launch velocity, especially for unproven brands. In many cases, a focused 3–5 SKU entry assortment performs better than introducing ten variants with weak differentiation. Brands should define hero SKUs, opening price points, and a replenishment-friendly core before thinking about expansion items.

Packaging choices can influence both compliance and economics. Unit size affects shelf productivity and perceived value. Secondary packaging may be necessary for some channels but wasteful for others. Claims hierarchy should support both conversion and regulatory discipline. If your US assortment needs adaptation, it is better to redesign for fit than to insist on global consistency that limits buyer acceptance or shopper understanding.

Takeaway: Adapt your assortment and messaging to US shopping behavior rather than assuming your home-market proposition will translate unchanged.

7. Support Launch With Ongoing Market Intelligence, Not a One-Time Plan

US entry is not complete when the product lands in market. Personal Care & OTC is highly dynamic, with constant shifts in pricing, promotional cadence, retailer assortment, consumer review trends, and compliance scrutiny. Brands that treat launch as a one-time project often miss the signals that matter most: a competitor’s pack-size change, a retailer’s category reset, a marketplace claim trend, or a widening gap between your MSRP and actual shelf price. The first 6–12 months after launch often determine whether a brand earns expansion or gets delisted.

This is where structured Industry Intel becomes valuable. Tracking competitive moves, retailer assortment changes, and category messaging trends helps brands refine their US strategy with evidence rather than instinct. For example, if a rival OTC topical brand is winning shelf because it communicates a more specific use case, your response may involve packaging changes, not more ad spend. If your Amazon conversion rate lags despite strong traffic, the issue may be content hierarchy, claim clarity, or review quality rather than awareness.

Founders and marketing directors should also review channel performance separately. A product can be healthy on Amazon but weak in specialty retail because the merchandising story is unclear. Or a line can perform well in independent wellness stores but fail in mass because promotional expectations destroy margin. Ongoing market intelligence helps you avoid broad conclusions based on one channel’s results.

Takeaway: Treat US expansion as a monitored operating system, with regular intelligence inputs guiding pricing, claims, assortment, and channel decisions.

Conclusion

Entering the US Personal Care & OTC market is attractive, but it rewards preparation more than speed. The brands that scale are the ones that get classification right, build regulatory compliance into every claim touchpoint, choose sensible retail channels, understand when to use a distributor, and show up to retail buyers with complete listing requirements already mapped. In 2026, strong products still matter, but operational maturity is what turns interest into distribution.

If you are planning global expansion into the United States, start with market evidence and compliance clarity before committing inventory and sales resources. US Brand Launch can help with a personalized US Launch Intelligence Report or a free Brand Readiness Score to assess your product, channel fit, and launch risks before you enter the market.